ALBUQUERQUE, N.M. (KRQE) – Psychedelics have long been known for their reality-altering effect, but could they also be an answer to mental health? That’s what researchers at UNM Health Sciences like Dr. Larry Leeman are trying to find out.
“We’re excited because these studies have been happening in other places but we’ve had not very many in UNM,” said Dr. Leeman.
University of Health Sciences researchers have two studies looking into psilocybin, found in what is commonly known as magic mushrooms. One study looks into whether a compound of psilocybin could quickly treat those suffering from postpartum depression.
“The hope is that this one may work more rapidly. It is related to psilocybin and psilocybin in other studies have been shown to work in a relatively short amount of days,” said Dr. Leeman. The second study looks into how psilocybin can help depression.
“Some of the things that this study is looking at that is different is do some people need multiple doses over a year? And what are the longer-term outcomes,” he said.
Participants will be monitored by researchers at their psychedelic therapy room and evaluated for 54 weeks. “I really try to distinguish with using them therapeutically which is what we’re focusing on in a safe setting with trained therapist,” said Dr. Leeman.
It’s the kind of research the state is encouraging. This past regular legislative session, the senate unanimously passed a resolution urging the New Mexico Department of Health and UNM Health Sciences to study psychedelics at treatment.
“I have friends who do have PTSD and it’s hard. It’s hard to find the right help and get the help and nobody wants to live with that. So if anything we can do to help the people, is what matters,” said Sen. Stefani Lord, a Republican who represents Bernalillo and Torrance Counties.
While these studies aren’t a direct response to that resolution, Dr. Leeman said they do fit into what lawmakers are asking for. “The studies so far are promising that psilocybin could be given what’s called breakthrough drug status by the FDA so it looks promising,” he said.
Psilocybin is still illegal in the United States. The results of these studies could contribute to it becoming FDA-approved for medical treatment. To read about the studies in further detail or learn how to participate in one, click here.